Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
<p>Abstract</p> <p>Background</p> <p>Data regarding CD4+ recovery after switching from protease inhibitor (PI)-based regimens to regimens not containing PI are scarce.</p> <p>Methods</p> <p>Subjects with virological success on first-PI-regimens w...
Main Authors: | Cicconi Paola, Castagna Antonella, Mussini Cristina, De Luca Andrea, Antinori Andrea, Cologni Giuliana, Lapadula Giuseppe, Pozniak Anton L, d'Arminio-Monforte Antonella, Torti Carlo, Minoli Lorenzo, Costantini Andrea, Carosi Giampiero, Liang Hua, Cesana Bruno M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/11/23 |
Similar Items
-
The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI
by: Shengnan Liu, et al.
Published: (2023-04-01) -
Guidelines for the prevention, diagnosis and management of NRTI-hyperlactataemia and lactic acidosis
by: Editorial Office
Published: (2006-05-01) -
Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
by: Vandercam Bernard, et al.
Published: (2010-05-01) -
Machine learning aided multiscale modelling of the HIV-1 infection in the presence of NRTI therapy
by: Huseyin Tunc, et al.
Published: (2023-03-01) -
DEVELOPMENT AND REGISTRATION OF A COMBINED DRUG FOR THE TREATMENT OF HIV INFECTION ON THE BASIS OF ON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTI) PHOSPHAZIDE AND LAMIVUDINE
by: A. F. Khohlov, et al.
Published: (2019-01-01)